1-11 of 11
Martee L. Hensley
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Histology-Specific Clinical Trial of Lenvatinib and Pembrolizumab in Patients with Sarcoma

Sujana Movva, Kenneth Seier, Viswatej Avutu, Lauren B. Banks, Jason Chan, Ping Chi, Mark A. Dickson, Mrinal M. Gounder, Ciara M. Kelly, Mary L. Keohan, Robert Maki, Evan Rosenbaum, Tiffany Salcito, Kaithleen Rodriguez, Rebecca Dempsey, Paul A. Meyers, Seth M. Cohen, Martee L. Hensley, Jason A. Konner, Alison M. Schram, Robert A. Lefkowitz, Joseph P. Erinjeri, Li-Xuan Qin, William D. Tap, Sandra P. D’Angelo
Journal: Clinical Cancer Research
Clin Cancer Res (2024) 30 (24): 5612–5619.
https://doi.org/10.1158/1078-0432.CCR-24-2519
Published: 16 December 2024
View articletitled, Histology-Specific Clinical Trial of Lenvatinib and Pembrolizumab in Patients with Sarcoma
Open the PDF for Histology-Specific Clinical Trial of Lenvatinib and Pembrolizumab in Patients with Sarcoma in another window
Includes: Supplementary data
Journal Articles

The Impact of Li‐Fraumeni and Germline Retinoblastoma Mutations on Leiomyosarcoma Initiation, Outcomes, and Genetic Testing Recommendations

Josephine K. Dermawan, David H. Abramson, Sarah Chiang, Martee L. Hensley, William D. Tap, Sujana Movva, Robert G. Maki, Diana Mandelker, Cristina R. Antonescu
Journal: Clinical Cancer Research
Clin Cancer Res (2024) 30 (20): 4780–4790.
https://doi.org/10.1158/1078-0432.CCR-24-1160
Published: 15 October 2024
View articletitled, The Impact of Li‐Fraumeni and Germline Retinoblastoma Mutations on Leiomyosarcoma Initiation, Outcomes, and Genetic Testing Recommendations
Open the PDF for The Impact of Li‐Fraumeni and Germline Retinoblastoma Mutations on Leiomyosarcoma Initiation, Outcomes, and Genetic Testing Recommendations in another window
Includes: Supplementary data
Journal Articles

Developing Novel Genomic Risk Stratification Models in Soft Tissue and Uterine Leiomyosarcoma

Josephine K. Dermawan, Sarah Chiang, Samuel Singer, Bhumika Jadeja, Martee L. Hensley, William D. Tap, Sujana Movva, Robert G. Maki, Cristina R. Antonescu
Journal: Clinical Cancer Research
Clin Cancer Res (2024) 30 (10): 2260–2271.
https://doi.org/10.1158/1078-0432.CCR-24-0148
Published: 15 May 2024
View articletitled, Developing Novel Genomic Risk Stratification Models in Soft Tissue and Uterine Leiomyosarcoma
Open the PDF for Developing Novel Genomic Risk Stratification Models in Soft Tissue and Uterine Leiomyosarcoma in another window
Includes: Supplementary data
Journal Articles

Genomic Landscape of Uterine Sarcomas Defined Through Prospective Clinical Sequencing

Martee L. Hensley, Shweta S. Chavan, David B. Solit, Rajmohan Murali, Robert Soslow, Sarah Chiang, Achim A. Jungbluth, Chaitanya Bandlamudi, Preethi Srinivasan, William D. Tap, Evan Rosenbaum, Barry S. Taylor, Mark T.A. Donoghue, David M. Hyman
Journal: Clinical Cancer Research
Clin Cancer Res (2020) 26 (14): 3881–3888.
https://doi.org/10.1158/1078-0432.CCR-19-3959
Published: 15 July 2020
View articletitled, Genomic Landscape of Uterine Sarcomas Defined Through Prospective Clinical Sequencing
Open the PDF for Genomic Landscape of Uterine Sarcomas Defined Through Prospective Clinical Sequencing in another window
Includes: Supplementary data
Journal Articles

Clinical Utility of Prospective Molecular Characterization in Advanced Endometrial Cancer

Tara E. Soumerai, Mark T.A. Donoghue, Chaitanya Bandlamudi, Preethi Srinivasan, Matthew T. Chang, Dmitriy Zamarin, Karen A. Cadoo, Rachel N. Grisham, Roisin E. O'Cearbhaill, William P. Tew, Jason A. Konner, Martee L. Hensley, Vicky Makker, Paul Sabbatini, David R. Spriggs, Tiffany A. Troso-Sandoval, Alexandra Snyder Charen, Claire Friedman, Mila Gorsky, Sarah J. Schweber, Sumit Middha, Rajmohan Murali, Sarah Chiang, Kay J. Park, Robert A. Soslow, Marc Ladanyi, Bob T. Li, Jennifer Mueller, Britta Weigelt, Ahmet Zehir, Michael F. Berger, Nadeem R. Abu-Rustum, Carol Aghajanian, Deborah F. DeLair, David B. Solit, Barry S. Taylor, David M. Hyman
Journal: Clinical Cancer Research
Clin Cancer Res (2018) 24 (23): 5939–5947.
https://doi.org/10.1158/1078-0432.CCR-18-0412
Published: 03 December 2018
View articletitled, Clinical Utility of Prospective Molecular Characterization in Advanced Endometrial Cancer
Open the PDF for Clinical Utility of Prospective Molecular Characterization in Advanced Endometrial Cancer in another window
Includes: Supplementary data
Journal Articles

Phase I Trial of Overlapping Long Peptides from a Tumor Self-Antigen and Poly-ICLC Shows Rapid Induction of Integrated Immune Response in Ovarian Cancer Patients

Paul Sabbatini, Takemasa Tsuji, Luis Ferran, Erika Ritter, Christine Sedrak, Kevin Tuballes, Achim A. Jungbluth, Gerd Ritter, Carol Aghajanian, Katherine Bell-McGuinn, Martee L. Hensley, Jason Konner, William Tew, David R. Spriggs, Eric W. Hoffman, Ralph Venhaus, Linda Pan, Andres M. Salazar, Catherine Magid Diefenbach, Lloyd J. Old, Sacha Gnjatic
Journal: Clinical Cancer Research
Clin Cancer Res (2012) 18 (23): 6497–6508.
https://doi.org/10.1158/1078-0432.CCR-12-2189
Published: 29 November 2012
View articletitled, Phase I Trial of Overlapping Long Peptides from a Tumor Self-Antigen and Poly-ICLC Shows Rapid Induction of Integrated Immune Response in Ovarian Cancer Patients
Open the PDF for Phase I Trial of Overlapping Long Peptides from a Tumor Self-Antigen and Poly-ICLC Shows Rapid Induction of Integrated Immune Response in Ovarian Cancer Patients in another window
Includes: Supplementary data
Journal Articles

Farletuzumab, a Humanized Monoclonal Antibody against Folate Receptor α, in Epithelial Ovarian Cancer: a Phase I Study

Jason A. Konner, Katherine M. Bell-McGuinn, Paul Sabbatini, Martee L. Hensley, William P. Tew, Neeta Pandit-Taskar, Nicholas Vander Els, Martin D. Phillips, Charles Schweizer, Susan C. Weil, Steven M. Larson, Lloyd J. Old
Journal: Clinical Cancer Research
Clin Cancer Res (2010) 16 (21): 5288–5295.
https://doi.org/10.1158/1078-0432.CCR-10-0700
Published: 31 October 2010
View articletitled, Farletuzumab, a Humanized Monoclonal Antibody against Folate Receptor α, in Epithelial Ovarian Cancer: a Phase I Study
Open the PDF for Farletuzumab, a Humanized Monoclonal Antibody against Folate Receptor α, in Epithelial Ovarian Cancer: a Phase I Study in another window
Journal Articles

A Phase I Trial of Pemetrexed Plus Gemcitabine Given Biweekly with B-Vitamin Support in Solid Tumor Malignancies or Advanced Epithelial Ovarian Cancer

Martee L. Hensley, Joseph Larkin, Matthew Fury, Scott Gerst, D. Fritz Tai, Paul Sabbatini, Jason Konner, Mauro Orlando, Tiana L. Goss, Carol A. Aghajanian
Journal: Clinical Cancer Research
Clin Cancer Res (2008) 14 (19): 6310–6316.
https://doi.org/10.1158/1078-0432.CCR-08-0338
Published: 30 September 2008
View articletitled, A Phase I Trial of Pemetrexed Plus Gemcitabine Given Biweekly with B-Vitamin Support in Solid Tumor Malignancies or Advanced Epithelial Ovarian Cancer
Open the PDF for A Phase I Trial of Pemetrexed Plus Gemcitabine Given Biweekly with B-Vitamin Support in Solid Tumor Malignancies or Advanced Epithelial Ovarian Cancer in another window
Journal Articles

Safety and Immunogenicity Study of NY-ESO-1b Peptide and Montanide ISA-51 Vaccination of Patients with Epithelial Ovarian Cancer in High-Risk First Remission

Catherine S.M. Diefenbach, Sacha Gnjatic, Paul Sabbatini, Carol Aghajanian, Martee L. Hensley, David R. Spriggs, Alexia Iasonos, Helen Lee, Bo Dupont, Sandra Pezzulli, Achim A. Jungbluth, Lloyd J. Old, Jakob Dupont
Journal: Clinical Cancer Research
Clin Cancer Res (2008) 14 (9): 2740–2748.
https://doi.org/10.1158/1078-0432.CCR-07-4619
Published: 01 May 2008
View articletitled, Safety and Immunogenicity Study of NY-ESO-1b Peptide and Montanide ISA-51 Vaccination of Patients with Epithelial Ovarian Cancer in High-Risk First Remission
Open the PDF for Safety and Immunogenicity Study of NY-ESO-1b Peptide and Montanide ISA-51 Vaccination of Patients with Epithelial Ovarian Cancer in High-Risk First Remission in another window
Journal Articles

Pilot Study of a Heptavalent Vaccine-Keyhole Limpet Hemocyanin Conjugate plus QS21 in Patients with Epithelial Ovarian, Fallopian Tube, or Peritoneal Cancer

Paul J. Sabbatini, Govind Ragupathi, Chandra Hood, Carol A. Aghajanian, Margrit Juretzka, Alexia Iasonos, Martee L. Hensley, Maria K. Spassova, Ouathek Ouerfelli, David R. Spriggs, William P. Tew, Jason Konner, Henrik Clausen, Nadeem Abu Rustum, Samuel J. Dansihefsky, Philip O. Livingston
Journal: Clinical Cancer Research
Clin Cancer Res (2007) 13 (14): 4170–4177.
https://doi.org/10.1158/1078-0432.CCR-06-2949
Published: 18 July 2007
View articletitled, Pilot Study of a Heptavalent Vaccine-Keyhole Limpet Hemocyanin Conjugate plus QS21 in Patients with Epithelial Ovarian, Fallopian Tube, or Peritoneal Cancer
Open the PDF for Pilot Study of a Heptavalent Vaccine-Keyhole Limpet Hemocyanin Conjugate plus QS21 in Patients with Epithelial Ovarian, Fallopian Tube, or Peritoneal Cancer in another window
Journal Articles

A Phase I Trial of the Novel Proteasome Inhibitor PS341 in Advanced Solid Tumor Malignancies

Carol Aghajanian, Steven Soignet, Don S. Dizon, Christine S. Pien, Julian Adams, Peter J. Elliott, Paul Sabbatini, Vincent Miller, Martee L. Hensley, Sandra Pezzulli, Christina Canales, Adil Daud, David R. Spriggs
Journal: Clinical Cancer Research
Clin Cancer Res (2002) 8 (8): 2505–2511.
Published: 01 August 2002
View articletitled, A Phase I Trial of the Novel Proteasome Inhibitor PS341 in Advanced Solid Tumor Malignancies
Open the PDF for A Phase I Trial of the Novel Proteasome Inhibitor PS341 in Advanced Solid Tumor Malignancies in another window